Persistent polyclonal B-cell lymphocytosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:300324OMIM:606445D72.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Persistent polyclonal B-cell lymphocytosis (PPBL) is a rare blood disorder in which the body produces too many B lymphocytes, a type of white blood cell that normally helps fight infections. Unlike many blood cancers, this condition is considered benign (not cancerous), though it shares some features with lymphoma that can make diagnosis tricky. The condition is characterized by a long-lasting increase in a specific type of B cell in the blood, elevated levels of a protein called immunoglobulin M (IgM), and the presence of unusual white blood cells with two connected nuclei, called binucleated lymphocytes. PPBL most commonly affects young to middle-aged women who smoke cigarettes. Many people with this condition have no symptoms at all, and it is often discovered by chance during routine blood tests. When symptoms do occur, they may include mild fatigue, an enlarged spleen (splenomegaly), or swollen lymph nodes. The condition tends to remain stable over many years, but in rare cases it may progress to a more serious blood disorder such as lymphoma. There is no specific cure for PPBL. Management focuses on regular monitoring through blood tests and clinical exams. Smoking cessation is strongly recommended, as tobacco use appears to play a significant role in the disease. In most cases, no active treatment is needed unless the condition progresses or causes significant symptoms. Doctors will typically watch the condition closely over time to ensure it does not transform into a lymphoma or other serious blood disease.

Also known as:

Key symptoms:

Higher than normal white blood cell count found on blood testsEnlarged spleenSwollen lymph nodesMild fatigue or tirednessElevated immunoglobulin M (IgM) levels in the bloodUnusual-looking white blood cells with two nuclei seen under the microscopeGenerally feeling well despite abnormal blood countsOccasional mild infections

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Persistent polyclonal B-cell lymphocytosis.

View clinical trials →

No actively recruiting trials found for Persistent polyclonal B-cell lymphocytosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Persistent polyclonal B-cell lymphocytosis community →

Specialists

15 foundView all specialists →
AF
António Figueiredo
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
JK
Jean-Dominique de Korwin
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
PF
Pierre Feugier
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
JB
Julien Broséus
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
XT
Xavier Troussard
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
JL
Jean-François Lesesve
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
AF
Ana Carolina Freitas
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
DP
Diogo Paulino
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
CS
Carlos Severino
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
MC
Máriam Calú
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
RB
Rui Barreira
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
NN
N Nadal
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
NA
N Auger
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
RM
Romain Morizot
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication
AB
A Bidet
Specialist
1 Persistent polyclonal B-cell lymphocytosis publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Persistent polyclonal B-cell lymphocytosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Persistent polyclonal B-cell lymphocytosisForum →

No community posts yet. Be the first to share your experience with Persistent polyclonal B-cell lymphocytosis.

Start the conversation →

Latest news about Persistent polyclonal B-cell lymphocytosis

No recent news articles for Persistent polyclonal B-cell lymphocytosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How often should I have blood tests to monitor my condition?,What specific changes in my blood work would concern you?,How important is it for me to quit smoking, and what resources can help?,What are the signs that my condition might be progressing to something more serious?,Should my family members be tested for this condition?,Do I need a bone marrow biopsy, and if so, why?,Are there any activities, medications, or supplements I should avoid?

Common questions about Persistent polyclonal B-cell lymphocytosis

What is Persistent polyclonal B-cell lymphocytosis?

Persistent polyclonal B-cell lymphocytosis (PPBL) is a rare blood disorder in which the body produces too many B lymphocytes, a type of white blood cell that normally helps fight infections. Unlike many blood cancers, this condition is considered benign (not cancerous), though it shares some features with lymphoma that can make diagnosis tricky. The condition is characterized by a long-lasting increase in a specific type of B cell in the blood, elevated levels of a protein called immunoglobulin M (IgM), and the presence of unusual white blood cells with two connected nuclei, called binucleated

How is Persistent polyclonal B-cell lymphocytosis inherited?

Persistent polyclonal B-cell lymphocytosis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Persistent polyclonal B-cell lymphocytosis typically begin?

Typical onset of Persistent polyclonal B-cell lymphocytosis is adult. Age of onset can vary across affected individuals.

Which specialists treat Persistent polyclonal B-cell lymphocytosis?

15 specialists and care centers treating Persistent polyclonal B-cell lymphocytosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.